Sometimes they increase estrogenic activity — depending on
the type of estrogen receptor present in this kind of tissue, say, in this case, the skin — and sometimes they increase it, like in the ovaries.
The researchers are collaborating with investigators at the University of Pennsylvania that have found that turning on a very specific
type of estrogen receptor on melanoma makes it vulnerable to immunotherapy.
Not exact matches
A second
type is a point mutation in the part
of the
receptor that binds
estrogen, causing the
receptor to become active even without
estrogen.
Researchers at the Icahn School
of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth
of a common
type of breast cancer known as «
estrogen receptor positive» (ER +), including ER + cancers that are resistant to standard treatments.
And the third
type is a translocation, in which half
of the
estrogen receptor gene is swapped for a completely unrelated gene from a different part
of the genome.
«And we found all three
types of «gain -
of - function» mutations in the
estrogen receptor gene ESR1 in the tumor samples.»
Perhaps shedding light on this mystery, the researchers found three different
types of mutations in the
estrogen receptor in patients whose cancer was resistant to anti-hormone therapy.
Currently, there are no molecularly targeted therapies aimed at triple - negative breast cancer, which is a
type of cancer negative for
estrogen receptor, progesterone
receptor and the HER2 protein — all key targets for current therapies.
TNBC is deadly because, unlike other
types of breast cancers such as
estrogen receptor (ER) positive or HER2 amplified breast tumours which have effective targeted therapy, TNBC tumours do not respond to targeted therapy.
Depending on characteristics such as how many tumor cells, blood vessel cells, and immune cells are touching each other, the tumor microenvironment can nearly triple the chance that a common
type of breast cancer (
estrogen -
receptor positive / HER2 negative) that has reached the lymph nodes will also metastasize, Condeelis and colleagues showed in a 2014 study
of 3,760 patients.
Triple - negative breast cancer (TNBC), a tumor
type defined by its lack
of estrogen receptor, progesterone
receptor, and Her2 (ERBB2) amplification, accounts for 16 %
of breast cancers.
«The treatment for breast cancer is currently dependent on the
type of breast cancer, defined by the
estrogen receptor, progesterone
receptor, and HER2 status.
Triple negative breast cancer is a
type of breast cancer that does not express
receptors for the hormones
estrogen and progesterone, or for human epidermal growth factor.
«We found a strong reduction in the risk
of estrogen -
receptor - negative [ER --RSB- breast cancer in particular, which is exciting because that
type of tumor, while rarer than
estrogen -
receptor - positive [ER +] tumors, tends to be aggressive.»
Two
types of anti-
estrogen drugs Tamoxifen (Nolvadex) and raloxifene (Evista) are part
of a drug class called selective
estrogen receptor modulators (SERMs).
A xenoestrogens will be recognized by the body as an
estrogen, and it will attach to the same
receptors as
estrogen, like a key fitting one
type of lock.